©2024 Stanford Medicine
Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
Not Recruiting
Trial ID: NCT00553826
Purpose
This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.
Official Title
Derivation of Primary Donor Cell Lines for Human Cell Reprogramming
Stanford Investigator(s)
Eligibility
Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian failure)
Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin biopsy sample due to skin condition in the underarm area.
Intervention(s):
procedure: Improving the scientific process of human cell reprogramming
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Tasha Kalista
6507259977